EC Neurology

Background: COVID-19 is a serious and fatal disease, especially for the elderly. In an aging society, dementia is also an important medical, social, and economic issue.

Purpose: Logistical support and survival of COVID-19 recovered patients with advanced dementia were reported.

Methods: The characteristics of 14 dementia patients who were transferred directly to our hospital after receiving inpatient COVID-19 treatment at another medical facility were described.

Results: Of the 14 patients, 10 (71%) were males and 4 (29%) were females, with a median age of 85, a minimum of 76, and a maximum of 98. All of the subjects demonstrated various dementia-related behaviors and psychiatric signs. At previous hospitals for COVID-19 treatment, the median length of stay was 30 days, with a minimum of 12 days and a maximum of 59 days. Our hospital’s median length of stay was 111 days, with a minimum of 22 days and a maximum of 350 days. Eleven (79%) were still alive, while 3 (21%) had died at the end of the observation period. The utilization rate of COVID-19 ready beds showed eight pandemic waves. The median, minimum, and maximum intervals were 66 days, 45 days, 109 days between the leading edge of each pandemic wave and the subjects’ admission to our hospital. All subjects had survival rates of 0.81 in 100 days and 0.81 in 200 days following admission.

Conclusion: We depicted the logistical supports and survival rate of COVID-19 recovered patients with advanced dementia who were directly transferred from hospitals to our hospital for dementia-related behaviors and psychiatric symptoms. We believe that COVID-19 recovered patients with dementia will have a similar prognosis to COVID-19 uninfected patients with dementia.

 Keywords: COVID-19; Dementia; Logistical Support; Survival Rate

1. DATA. WHO COVID-19 (2024).
2. Ministry of Health, Labour and Welfare of Japan. “Visualizing the data: information on COVID-19 infections” (2023).
3. Miller IF., et al. “Disease and healthcare burden of COVID-19 in the United States”. Nature Medicine 8 (2020): 1212-1217.
4. Arsenault C., et al. “COVID-19 and resilience of healthcare systems in ten countries”. Nature Medicine 28 (2022): 1314-1324.
5. Saitama Prefecture of Japan. Subsidy for medical care delivery system support project for new type coronavirus infections in Saitama Prefecture in FY2022 (2023).
6. Saitama Prefecture of Japan. Information on confirmed infections and related information-novel coronavirus infection (2023).
7. Statistics Bureau of Japan. Statistics. Statistical topics No132. Japan's Elderly People in Statistics (2024).
8. Ministry of Health, Labour and Welfare Bureau of Elderly Health, Social security council. Comprehensive promotion of dementia measures June 20, 2020 (2024).
9. Kuboyama I., et al. “The number of patients with dementia in Saitama Prefecture”. Saitama Medical Journal 57 (2023): 389-393.
10. van Gerwen M., et al. “Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study”. Journal of Medical Virology 2 (2021): 907-915.
11. Reyes-Bueno JA., et al. “Case fatality of COVID-19 in patients with neurodegenerative dementia”. Neurologia9 (2020): 639-645.
12. Miyashita S., et al. “Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York”. Geriatrics and Gerontology International 7 (2020) 732-734.
13. Esme M., et al. “Older adults with coronavirus disease 2019: A nationwide study in Turkey”. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 3 (2021): e68-e75.
14. Mitchell SL., et al. “The clinical course of advanced dementia”. New England Journal of Medicine 16 (2009): 1529-1538.
15. Harb AA., et al. “Clinical features and outcomes of patients with dementia compared to an aging cohort hospitalized during the initial New York City COVID-19 wave”. Journal of Alzheimer's Disease 2 (2021): 679-690.
16. Bianchetti A., et al. “Clinical presentation of COVID19 in dementia patients”. Journal of Nutrition, Health and Aging 6 (2020): 560-562.
17. Poloni TE., et al. “Prevalence and prognostic value of delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study”. EClinicalMedicine 26 (2020): 100490.
18. Rothman KJ., et al. “Modern epidemiology”. Philadelphia, Lippincott Williams & Wilkins (2008): 128-147.